UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 387

Sortiert nach

Effects of isometric hip movements on electromyographic activities of the trunk muscles during plank exercises

Journal of Physical Therapy Science, 2016, Vol.28(8), pp.2373-2375

2016

Volltextzugriff (PDF)

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer

Scientific reports, 2023-06, Vol.13 (1), p.9928-9928, Article 9928

2023

Volltextzugriff (PDF)

The efficacy and safety of high-intensity interval training in chemotherapy-related cardiomyopathy: Report of two cases

Türkiye fiziksel tip ve rehabilitasyon dergisi, 2022-06, Vol.68 (2), p.286

2022

Volltextzugriff (PDF)

Clinical effect of reduced‐intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated‐donors

American journal of hematology, 2011-05, Vol.86 (5), p.399-405

2011

Volltextzugriff (PDF)

Treatment pattern of chronic lymphocytic leukemia/small lymphocytic lymphoma in Korea: a multicenter retrospective study (KCSG LY20-06)

The Korean Journal of Internal Medicine, 2023, 38(5), , pp.747-757

2023

Volltextzugriff (PDF)

Health inequalities in hypertension and diabetes management among the poor in urban areas: a population survey analysis in south Korea

BMC public health, 2016-06, Vol.16 (1), p.492-492, Article 492

2016

Volltextzugriff (PDF)

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Therapeutic advances in medical oncology, 2021-12, Vol.13, p.17588359211061989-17588359211061989

2021

Volltextzugriff (PDF)

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920923424-1758835920923424

2020

Volltextzugriff (PDF)

The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study

The Korean Journal of Internal Medicine, 2019, 34(1), , pp.165-177

2019

Volltextzugriff (PDF)

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Vol.20 (1), p.182-189

2017

Volltextzugriff (PDF)

The efficacy of TachoComb on reducing postoperative complications after tonsillectomy in children

International journal of pediatric otorhinolaryngology, 2015-08, Vol.79 (8), p.1337-1340

2015

Volltextzugriff (PDF)

Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience

Cancer chemotherapy and pharmacology, 2013-07, Vol.72 (1), p.201-207

2013

Volltextzugriff (PDF)

Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

World journal of gastroenterology : WJG, 2012-03, Vol.18 (10), p.1104-1109

2012

Volltextzugriff (PDF)

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

The lancet oncology, 2021-11, Vol.22 (11), p.1560-1572

2021

Volltextzugriff (PDF)

A Large Pericardial Cyst Compressing the Left Atrium Presenting as a Pericardiopleural Efussion

Heart, lung & circulation, 2014-12, Vol.23 (12), p.e273-e275

2014

Volltextzugriff (PDF)

Enantioselective Synthetic Method for α-Alkylserine via Phase-Transfer Catalytic Alkylation of 2-Phenyl-2-oxazoline-4- carbonylcamphorsultam

Journal of organic chemistry, 2005-05, Vol.70 (10), p.4158-4161

2005

Volltextzugriff (PDF)

Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability‐high/mismatch repair‐deficient or POLE‐mutated metastatic or unresectable colorectal cancer

International journal of cancer, 2022-06, Vol.150 (12), p.2038-2045

2022

Volltextzugriff (PDF)

Serum vitamin D 3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.613-613

2023

Volltextzugriff (PDF)

Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study

Liver international, 2020-10, Vol.40 (10), p.2544-2552

2020

Volltextzugriff (PDF)

Trastuzumab plus FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer: A multi-institutional phase II trial of the Korean Cancer Study Group (KCSG-HB19-14)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4096-4096

2022

Volltextzugriff (PDF)

Liposomal irinotecan (nal-IRI) in combination with fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic biliary tract cancer (BTC) after progression on gemcitabine plus cisplatin (GemCis): Multicenter comparative randomized phase 2b study (NIFTY)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4006-4006

2021

Volltextzugriff (PDF)

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

The lancet. Gastroenterology & hepatology, 2023-01, Vol.8 (1), p.56-65

2023

Volltextzugriff (PDF)

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial

JAMA oncology, 2023-05, Vol.9 (5), p.692

2023

Volltextzugriff (PDF)

1 – 25 von 387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(351)
Mit Volltextzugriff
(374)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(228)
Life Sciences & Biomedicine
(170)
Humans
(109)
Male
(85)
Female
(75)
Middle Aged
(68)
Adult
(44)
Pharmacology & Pharmacy
(42)
Aged
(41)
Physical Sciences
(39)
Chemistry
(36)
Animals
(31)
Technology
(29)
Biological And Medical Sciences
(26)
Original
(25)
Treatment Outcome
(24)
Retrospective Studies
(23)
Oncology
(22)
Medical Sciences
(21)
Science & Technology - Other Topics
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Effects of isometric hip movements on electromyographic activities of the trunk muscles during plank exercises

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer

The efficacy and safety of high-intensity interval training in chemotherapy-related cardiomyopathy: Report of two cases

Clinical effect of reduced‐intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated‐donors

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)

Treatment pattern of chronic lymphocytic leukemia/small lymphocytic lymphoma in Korea: a multicenter retrospective study (KCSG LY20-06)

Health inequalities in hypertension and diabetes management among the poor in urban areas: a population survey analysis in south Korea

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

The efficacy of TachoComb on reducing postoperative complications after tonsillectomy in children

Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience

Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

A Large Pericardial Cyst Compressing the Left Atrium Presenting as a Pericardiopleural Efussion

Enantioselective Synthetic Method for α-Alkylserine via Phase-Transfer Catalytic Alkylation of 2-Phenyl-2-oxazoline-4- carbonylcamphorsultam

Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability‐high/mismatch repair‐deficient or POLE‐mutated metastatic or unresectable colorectal cancer

Serum vitamin D 3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort

Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study

Trastuzumab plus FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer: A multi-institutional phase II trial of the Korean Cancer Study Group (KCSG-HB19-14)

Liposomal irinotecan (nal-IRI) in combination with fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic biliary tract cancer (BTC) after progression on gemcitabine plus cisplatin (GemCis): Multicenter comparative randomized phase 2b study (NIFTY)

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial

Suchergebnisse filtern